Cellectis Presents First Preclinical Data on UCARTMESO, an Allogeneic CAR-T Cell Product Candidate Targeting Mesothelin to Treat Solid Tumors at the Annual Meeting of the Society for Immunotherapy of Cancer

Matt Turner
Patient Affordability

Bud Bilanich
Success Coach

Pat Purcell
Meeting Engagement

Paul Theisen
Patient Acquisition

Stacey Gandler
Brand Nourishment

Frank Burrell
Scientific Storytelling

Matthew Durham
Omnidynamic Marketing

David Linetsky
Point-of-Care Marketing

Joey Cohen
Medication Adherence

Daniel Sontupe
Market Access

Suma Ramadas, PhD
Medical Affairs

Brenda Snow
Authentic Patient Voice

Amy Giles
Increasing Engagement

Liz Kane
Impactful Strategy